Report Cover

United States Gastroparesis Drugs Market Report & Forecast 2021-2027


United States Gastroparesis Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kg)
United States Gastroparesis Drugs Market Segment Percentages, By Type, 2020 (%)
    Prokinetic Agents
    Antiemetic Agents
    Others

United States Gastroparesis Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kg)
United States Gastroparesis Drugs Market Segment Percentages, By Application, 2020 (%)
    Diabetic Gastroparesis
    Idiopathic Gastroparesis

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastroparesis Drugs revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Gastroparesis Drugs revenues share in United States market, 2020 (%)
Key companies Gastroparesis Drugs sales in United States market, 2016-2021 (Estimated), (Kg)
Key companies Gastroparesis Drugs sales share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Sumitomo
    Cadila Pharmaceuticals
    Sanofi
    Teva
    Johnson & Johnson
    Pfizer
    Kyowa Kirin Pharmaceuticals
    Hanmi Pharm
    Ani Pharmaceuticals
1 Introduction to Research & Analysis Reports
    1.1 Gastroparesis Drugs Market Definition
    1.2 Market Segments
        1.2.1 Segment by Type
        1.2.2 Segment by Application
    1.3 United States Gastroparesis Drugs Market Overview
    1.4 Methodology & Sources of Information
        1.4.1 Research Methodology
        1.4.2 Research Process
        1.4.3 Base Year

2 United States Gastroparesis Drugs Overall Market Size
    2.1 United States Gastroparesis Drugs Market Size: 2021 VS 2027
    2.2 United States Gastroparesis Drugs Revenue, Prospects & Forecasts: 2016-2027
    2.3 United States Gastroparesis Drugs Sales: 2016-2027

3 Company Landscape
    3.1 Top Gastroparesis Drugs Players in United States Market
    3.2 Top United States Gastroparesis Drugs Companies Ranked by Revenue
    3.3 United States Gastroparesis Drugs Revenue by Companies
    3.4 United States Gastroparesis Drugs Sales by Companies
    3.5 United States Gastroparesis Drugs Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Gastroparesis Drugs Companies in United States Market, by Revenue in 2020
    3.7 Manufacturers Gastroparesis Drugs Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Gastroparesis Drugs Players in United States Market
        3.8.1 List of Tier 1 Gastroparesis Drugs Companies in United States
        3.8.2 List of Tier 2 and Tier 3 Gastroparesis Drugs Companies in United States

4 Sights by Type
    4.1 Overview
        4.1.1 By Type - United States Gastroparesis Drugs Market Size Markets, 2021 & 2027
        4.1.2 Prokinetic Agents
        4.1.3 Antiemetic Agents
        4.1.4 Others
    4.2 By Type - United States Gastroparesis Drugs Revenue & Forecasts
        4.2.1 By Type - United States Gastroparesis Drugs Revenue, 2016-2021
        4.2.2 By Type - United States Gastroparesis Drugs Revenue, 2022-2027
        4.2.3 By Type - United States Gastroparesis Drugs Revenue Market Share, 2016-2027
    4.3 By Type - United States Gastroparesis Drugs Sales & Forecasts
        4.3.1 By Type - United States Gastroparesis Drugs Sales, 2016-2021
        4.3.2 By Type - United States Gastroparesis Drugs Sales, 2022-2027
        4.3.3 By Type - United States Gastroparesis Drugs Sales Market Share, 2016-2027
    4.4 By Type - United States Gastroparesis Drugs Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
    5.1 Overview
        5.1.1 By Application - United States Gastroparesis Drugs Market Size, 2021 & 2027
        5.1.2 Diabetic Gastroparesis
        5.1.3 Idiopathic Gastroparesis
    5.2 By Application - United States Gastroparesis Drugs Revenue & Forecasts
        5.2.1 By Application - United States Gastroparesis Drugs Revenue, 2016-2021
        5.2.2 By Application - United States Gastroparesis Drugs Revenue, 2022-2027
        5.2.3 By Application - United States Gastroparesis Drugs Revenue Market Share, 2016-2027
    5.3 By Application - United States Gastroparesis Drugs Sales & Forecasts
        5.3.1 By Application - United States Gastroparesis Drugs Sales, 2016-2021
        5.3.2 By Application - United States Gastroparesis Drugs Sales, 2022-2027
        5.3.3 By Application - United States Gastroparesis Drugs Sales Market Share, 2016-2027
    5.4 By Application - United States Gastroparesis Drugs Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
    6.1 Sumitomo
        6.1.1 Sumitomo Corporation Information
        6.1.2 Sumitomo Overview
        6.1.3 Sumitomo Gastroparesis Drugs Sales and Revenue in United States Market (2016-2021)
        6.1.4 Sumitomo Gastroparesis Drugs Product Description
        6.1.5 Sumitomo Recent Developments
    6.2 Cadila Pharmaceuticals
        6.2.1 Cadila Pharmaceuticals Corporation Information
        6.2.2 Cadila Pharmaceuticals Overview
        6.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Sales and Revenue in United States Market (2016-2021)
        6.2.4 Cadila Pharmaceuticals Gastroparesis Drugs Product Description
        6.2.5 Cadila Pharmaceuticals Recent Developments
    6.3 Sanofi
        6.3.1 Sanofi Corporation Information
        6.3.2 Sanofi Overview
        6.3.3 Sanofi Gastroparesis Drugs Sales and Revenue in United States Market (2016-2021)
        6.3.4 Sanofi Gastroparesis Drugs Product Description
        6.3.5 Sanofi Recent Developments
    6.4 Teva
        6.4.1 Teva Corporation Information
        6.4.2 Teva Overview
        6.4.3 Teva Gastroparesis Drugs Sales and Revenue in United States Market (2016-2021)
        6.4.4 Teva Gastroparesis Drugs Product Description
        6.4.5 Teva Recent Developments
    6.5 Johnson & Johnson
        6.5.1 Johnson & Johnson Corporation Information
        6.5.2 Johnson & Johnson Overview
        6.5.3 Johnson & Johnson Gastroparesis Drugs Sales and Revenue in United States Market (2016-2021)
        6.5.4 Johnson & Johnson Gastroparesis Drugs Product Description
        6.5.5 Johnson & Johnson Recent Developments
    6.6 Pfizer
        6.6.1 Pfizer Corporation Information
        6.6.2 Pfizer Overview
        6.6.3 Pfizer Gastroparesis Drugs Sales and Revenue in United States Market (2016-2021)
        6.6.4 Pfizer Gastroparesis Drugs Product Description
        6.6.5 Pfizer Recent Developments
    6.7 Kyowa Kirin Pharmaceuticals
        6.7.1 Kyowa Kirin Pharmaceuticals Corporation Information
        6.7.2 Kyowa Kirin Pharmaceuticals Overview
        6.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales and Revenue in United States Market (2016-2021)
        6.7.4 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Description
        6.7.5 Kyowa Kirin Pharmaceuticals Recent Developments
    6.8 Hanmi Pharm
        6.8.1 Hanmi Pharm Corporation Information
        6.8.2 Hanmi Pharm Overview
        6.8.3 Hanmi Pharm Gastroparesis Drugs Sales and Revenue in United States Market (2016-2021)
        6.8.4 Hanmi Pharm Gastroparesis Drugs Product Description
        6.8.5 Hanmi Pharm Recent Developments
    6.9 Ani Pharmaceuticals
        6.9.1 Ani Pharmaceuticals Corporation Information
        6.9.2 Ani Pharmaceuticals Overview
        6.9.3 Ani Pharmaceuticals Gastroparesis Drugs Sales and Revenue in United States Market (2016-2021)
        6.9.4 Ani Pharmaceuticals Gastroparesis Drugs Product Description
        6.9.5 Ani Pharmaceuticals Recent Developments

7 United States Gastroparesis Drugs Production Capacity, Analysis
    7.1 United States Gastroparesis Drugs Production Capacity, 2016-2027
    7.2 Gastroparesis Drugs Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
    8.1 Market Opportunities & Trends
    8.2 Market Drivers
    8.3 Market Restraints

9 Gastroparesis Drugs Supply Chain Analysis
    9.1 Gastroparesis Drugs Industry Value Chain
    9.2 Gastroparesis Drugs Upstream Market
    9.3 Gastroparesis Drugs Downstream and Clients
    9.4 Marketing Channels Analysis
        9.4.1 Marketing Channels
        9.4.2 Gastroparesis Drugs Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
    11.1 Note
    11.2 Examples of Clients
    11.3 Author Details
    11.4 Disclaimer

List of Tables Table 1. Key Players of Gastroparesis Drugs in United States Market Table 2. Top Gastroparesis Drugs Players in United States Market, Ranking by Revenue (2019) Table 3. United States Gastroparesis Drugs Revenue by Companies, (US$, Mn), 2016-2021 Table 4. United States Gastroparesis Drugs Revenue Share by Companies, 2016-2021 Table 5. United States Gastroparesis Drugs Sales by Companies, (Kg), 2016-2021 Table 6. United States Gastroparesis Drugs Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Gastroparesis Drugs Price (2016-2021) & (US$/mg) Table 8. Manufacturers Gastroparesis Drugs Product Type Table 9. List of Tier 1 Gastroparesis Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Gastroparesis Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of Prokinetic Agents Table 12. Major Manufacturers of Antiemetic Agents Table 13. By Type - United States Gastroparesis Drugs Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - United States Gastroparesis Drugs Revenue (US$, Mn), 2016-2021 Table 15. By Type - United States Gastroparesis Drugs Revenue (US$, Mn), 2022-2027 Table 16. By Type - United States Gastroparesis Drugs Sales (Kg), 2016-2021 Table 17. By Type - United States Gastroparesis Drugs Sales (Kg), 2022-2027 Table 18. By Application - United States Gastroparesis Drugs Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - United States Gastroparesis Drugs Revenue (US$, Mn), 2016-2021 Table 20. By Application - United States Gastroparesis Drugs Revenue (US$, Mn), 2022-2027 Table 21. By Application - United States Gastroparesis Drugs Sales (Kg), 2016-2021 Table 22. By Application - United States Gastroparesis Drugs Sales (Kg), 2022-2027 Table 23. Sumitomo Corporation Information Table 24. Sumitomo Description and Major Businesses Table 25. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021) Table 26. Sumitomo Gastroparesis Drugs Product Table 27. Sumitomo Recent Developments Table 28. Cadila Pharmaceuticals Corporation Information Table 29. Cadila Pharmaceuticals Description and Major Businesses Table 30. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021) Table 31. Cadila Pharmaceuticals Gastroparesis Drugs Product Table 32. Cadila Pharmaceuticals Recent Developments Table 33. Sanofi Corporation Information Table 34. Sanofi Description and Major Businesses Table 35. Sanofi Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021) Table 36. Sanofi Gastroparesis Drugs Product Table 37. Sanofi Recent Developments Table 38. Teva Corporation Information Table 39. Teva Description and Major Businesses Table 40. Teva Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021) Table 41. Teva Gastroparesis Drugs Product Table 42. Teva Recent Developments Table 43. Johnson & Johnson Corporation Information Table 44. Johnson & Johnson Description and Major Businesses Table 45. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021) Table 46. Johnson & Johnson Gastroparesis Drugs Product Table 47. Johnson & Johnson Recent Developments Table 48. Pfizer Corporation Information Table 49. Pfizer Description and Major Businesses Table 50. Pfizer Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021) Table 51. Pfizer Gastroparesis Drugs Product Table 52. Pfizer Recent Developments Table 53. Kyowa Kirin Pharmaceuticals Corporation Information Table 54. Kyowa Kirin Pharmaceuticals Description and Major Businesses Table 55. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021) Table 56. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Table 57. Kyowa Kirin Pharmaceuticals Recent Developments Table 58. Hanmi Pharm Corporation Information Table 59. Hanmi Pharm Description and Major Businesses Table 60. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021) Table 61. Hanmi Pharm Gastroparesis Drugs Product Table 62. Hanmi Pharm Recent Developments Table 63. Ani Pharmaceuticals Corporation Information Table 64. Ani Pharmaceuticals Description and Major Businesses Table 65. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021) Table 66. Ani Pharmaceuticals Gastroparesis Drugs Product Table 67. Ani Pharmaceuticals Recent Developments Table 68. Gastroparesis Drugs Production Capacity (Kg) of Key Manufacturers in United States Market, 2019-2021 (Kg) Table 69. United States Gastroparesis Drugs Capacity Market Share of Key Manufacturers, 2019-2021 Table 70. Gastroparesis Drugs Market Opportunities & Trends in United States Market Table 71. Gastroparesis Drugs Market Drivers in United States Market Table 72. Gastroparesis Drugs Market Restraints in United States Market Table 73. Gastroparesis Drugs Raw Materials Table 74. Gastroparesis Drugs Raw Materials Suppliers in United States Market Table 75. Typical Gastroparesis Drugs Downstream Table 76. Gastroparesis Drugs Downstream Clients in United States Market Table 77. Gastroparesis Drugs Distributors and Sales Agents in United States Market List of Figures Figure 1. Gastroparesis Drugs Product Picture Figure 2. Gastroparesis Drugs Segment by Type Figure 3. Gastroparesis Drugs Segment by Application Figure 4. United States Gastroparesis Drugs Market Overview: 2020 Figure 5. United States Gastroparesis Drugs Market Size: 2021 VS 2027 (US$, Mn) Figure 6. United States Gastroparesis Drugs Revenue, 2016-2027 (US$, Mn) Figure 7. Gastroparesis Drugs Sales in United States Market: 2016-2027 (Kg) Figure 8. The Top 3 and 5 Players Market Share by Gastroparesis Drugs Revenue in 2020 Figure 9. Prokinetic Agents Product Picture Figure 10. Antiemetic Agents Product Picture Figure 11. Others Product Picture Figure 12. By Type - United States Gastroparesis Drugs Sales Market Share, 2016-2027 Figure 13. By Type - United States Gastroparesis Drugs Revenue Market Share, 2016-2027 Figure 14. By Type - United States Gastroparesis Drugs Price (US$/mg), 2016-2027 Figure 15. Diabetic Gastroparesis Figure 16. Idiopathic Gastroparesis Figure 17. By Application - United States Gastroparesis Drugs Sales Market Share, 2016-2027 Figure 18. By Application - United States Gastroparesis Drugs Revenue Market Share, 2016-2027 Figure 19. By Application - United States Gastroparesis Drugs Price (US$/mg), 2016-2027 Figure 20. Sumitomo Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 21. Cadila Pharmaceuticals Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 22. Sanofi Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 23. Teva Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 24. Johnson & Johnson Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 25. Pfizer Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 26. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 27. Hanmi Pharm Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 28. Ani Pharmaceuticals Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 29. United States Gastroparesis Drugs Production Capacity (Kg), 2016-2027 Figure 30. Gastroparesis Drugs Industry Value Chain Figure 31. Marketing Channels

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us